How is Picks disease diagnosed?

TL;DR: Diagnosing Pick’s disease, a rare form of frontotemporal dementia (FTD), is a complex process involving a combination of clinical evaluation, neuropsychological testing, and advanced neuroimaging to rule out other causes of cognitive decline. Because there is no single definitive test for Pick’s disease during a patient's lifetime, diagnosis relies on identifying specific patterns of behavioral or language changes alongside characteristic brain atrophy seen on MRI or PET scans.

How is Pick’s disease diagnosed by medical professionals?

The diagnostic process for Pick’s disease typically begins with a comprehensive physical and neurological examination. Because Pick’s disease often presents with personality changes, social disinhibition, or language impairment rather than memory loss, doctors must distinguish it from more common conditions like Alzheimer’s disease. Neurologists or behavioral neurologists assess the patient's cognitive function using standardized tools like the Mini-Mental State Examination (MMSE) or more sensitive neuropsychological batteries. These tests help identify deficits in executive function, social cognition, and language, which are hallmark indicators of Pick’s disease.

What tests and imaging are used to identify Pick’s disease?

There is currently no simple blood test to confirm Pick’s disease. Instead, clinical diagnosis relies on the following investigative tools:

• Structural MRI: Used to visualize focal atrophy (shrinkage) in the frontal and temporal lobes of the brain, a key structural marker of Pick’s disease.


• FDG-PET Scans: These scans measure glucose metabolism in the brain, often showing reduced activity in the frontal and temporal regions before significant atrophy is visible on an MRI.


• Neuropsychological Testing: Detailed assessments to map specific cognitive deficits, such as impaired impulse control or speech production.


• Lumbar Puncture (Cerebrospinal Fluid Analysis): Sometimes used to rule out Alzheimer’s disease by checking for levels of amyloid-beta and tau proteins.


• Genetic Testing: While most cases are sporadic, genetic counseling and testing may be recommended if there is a strong family history of dementia to check for mutations in genes such as MAPT or GRN.

Why is there often a long "diagnostic odyssey" for patients?

We recognize the profound frustration and isolation many families feel when seeking a diagnosis for Pick’s disease. Patients often experience a "diagnostic odyssey" because symptoms of Pick’s disease—such as irritability, apathy, or compulsive behaviors—are frequently misdiagnosed as depression, bipolar disorder, or midlife crises. On average, it can take several years for a patient to receive an accurate diagnosis, especially if they are younger than 65. Our community at DiseaseMaps.org, which includes 19 members sharing their experiences with Pick’s disease, often highlights the relief that comes from finally identifying the underlying cause of these challenging symptoms.

What conditions are commonly confused with Pick’s disease?

Differential diagnosis is crucial because Pick’s disease mimics several other neurological and psychiatric conditions. Physicians must differentiate it from Alzheimer’s disease (which typically affects memory first), vascular dementia, primary progressive aphasia, and even primary psychiatric disorders like schizophrenia or late-onset depression. Because of this complexity, it is vital to consult with a specialist, such as a behavioral neurologist or a neuro-psychiatrist, who has specific experience with frontotemporal degeneration.

Next steps

• Seek a specialist: Request a referral to an academic memory disorder clinic or a center specializing in frontotemporal dementia.


• Document symptoms: Keep a detailed log of behavioral and language changes to share with your medical team.


• Join our community: Connect with others at DiseaseMaps.org to share experiences and learn from the 19 community members currently managing Pick’s disease.


• Engage in research: Ask your physician about clinical trials or longitudinal studies for frontotemporal dementias.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult a qualified healthcare professional for diagnosis and treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Pick’s Disease Overview.


• Orphanet: Frontotemporal dementia (ORPHA: 73244).


• The Association for Frontotemporal Degeneration (AFTD): Diagnostic criteria and resources.


• OMIM (Online Mendelian Inheritance in Man): Entry #172700 (Pick disease of the brain).